Breast masses might be a mass discovered by patients incidentally
during breast self-examination or else by the physician during routine
physical examination. These masses have a variable etiology and
nature. while, Fibroadenoma considered the most common benign
breast mass, contrary, invasive ductal carcinoma is the most common
malignancy [1]. Although, the vast majority of these masses are
benign, still breast cancer is the furthermost frequently resulting
malignancy in females worldwide having an age-standardized
incidence rate (ASR) of 39.0 per 100,000 females, and the second
leading cause of cancer deaths in women [2-4]. In spite of most breast
cancers occur in women older than 50 years, one third of women
diagnosed with breast cancer between 1996 and 2000 were younger
than 50 years [5,6]. Contempt of medical advances and assuring
treatment regime, morbidity and mortality due to breast cancer has
seen no signicant changes in developing countries. In the US in 2020,
estimations reach 276,480 new cases of invasive breast cancer in
women ,and an additional 48,530 cases of ductal carcinoma in situ
diagnosed in women [7]. Also, an estimated mortality of 42,170
female patients with breast cancer will occur in 2020. Invasive female
breast cancer incidence rates trends increased slightly, by 0.3% per
year [2,6,8]. This might probably be due to lack of systematic
screening and early detection